Holen Sie sich die Stockscreener-App
8.28
4.81%
0.38
Vorhandelsmarkt:
8.51
0.23
+2.78%
Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten
GYRE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - Quantisnow
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction - Yahoo Finance
GNI Group’s Gyre Therapeutics to acquire Cullgen in $300 million all-stock deal - TipRanks
Gyre, Cullgen Merge In $300M All-Stock Deal - Law360
Gyre Therapeutics (NASDAQ:GYRE) Trading Up 8.2%Should You Buy? - MarketBeat
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Stocktwits
H.C. Wainwright reiterates Buy on Gyre Therapeutics stock By Investing.com - Investing.com UK
H.C. Wainwright reiterates Buy on Gyre Therapeutics stock - Investing.com Nigeria
Gyre Therapeutics to Acquire Cullgen in All-Stock Merger - TipRanks
Gyre Therapeutics (NASDAQ: GYRE) inks $300M all-stock Cullgen deal - Stock Titan
Gyre Therapeutics enters into agreement to acquire Cullgen to gain targeted protein degradation platform and pipeline - marketscreener.com
Gyre Therapeutics Enters Into Agreement To Acquire Cullgen To Gain Targeted Protein Degradation Platform And Pipeline - TradingView
Gyre Therapeutics to acquire Cullgen for $300 million - Investing.com
Gyre Therapeutics Enters into Agreement to Acquire Cullgen - GlobeNewswire
getLinesFromResByArray error: size == 0 - mfd.ru
Gyre Therapeutics, Inc. entered into an agreement to acquire Cullgen Inc. - marketscreener.com
Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a 111% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Risks Report: Can Gyre Therapeutics Inc expand into new marketsJuly 2025 Macro Moves & Precise Swing Trade Alerts - baoquankhu1.vn
Big Picture: How do insiders feel about Gyre Therapeutics Inc2025 Valuation Update & Trade Opportunity Analysis - baoquankhu1.vn
GYREGyre Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Aug Selloffs: Can Gyre Therapeutics Inc expand into new marketsJuly 2025 Earnings & Accurate Intraday Trading Signals - baoquankhu1.vn
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Given Average Recommendation of “Hold” by Brokerages - Defense World
Can Gyre Therapeutics Inc. scale operations efficientlyJuly 2025 Weekly Recap & Daily Entry Point Trade Alerts - mfd.ru
Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Capitalizing on a Promising 113.78% Upside - DirectorsTalk Interviews
Market Catalysts: Can Gyre Therapeutics Inc weather a recessionTreasury Yields & Daily Entry Point Trade Alerts - baoquankhu1.vn
Can Gyre Therapeutics Inc. maintain its current growth ratePortfolio Update Report & Safe Entry Zone Tips - mfd.ru
GNI Group Delays 2026 Earnings Forecast Amid Regulatory and Pipeline Uncertainty - TipRanks
High Growth Tech Stocks in US for February 2026 - simplywall.st
Will Gyre Therapeutics Inc outperform tech stocks2025 Price Action Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) Last Week's 8.5% Decline Must Have Disappointed Public Companies Who Have a Significant Stake - 富途牛牛
Returns Recap: Is TENPREs ROIC above industry averageWeekly Investment Report & Expert Curated Trade Setups - baoquankhu1.vn
Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a Promising 139.68% Upside Potential - DirectorsTalk Interviews
Gyre Therapeutics slumps 16%, prices $20M stock offering - MSN
What dividend growth rate does Gyre Therapeutics Inc. offer2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - mfd.ru
Analyzing Gyre Therapeutics (NASDAQ:GYRE) and ImmunityBio (NASDAQ:IBRX) - Defense World
Gyre Therapeutics, Inc. (GYRE) Investor Outlook: Eyeing a 119% Upside with a Strong Buy Consensus - DirectorsTalk Interviews
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 2.4%Still a Buy? - MarketBeat
Big Money Moves: Is MicroSectors Travel 3X Leveraged ETNs due May 29 2042 showing insider buyingWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Aug Big Picture: Is Gyre Therapeutics Inc a turnaround storyJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Trade Recap: Can Palantir Technologies Inc navigate macro headwindsMarket Risk Report & Long Hold Capital Preservation Plans - baoquankhu1.vn
Gyre Therapeutics, Inc. (GYRE) Investor Outlook: A Potential 123% Upside in the Biotech Space - DirectorsTalk Interviews
US Stocks Recap: Can Gyre Therapeutics Inc expand into new marketsWeekly Trade Analysis & Community Driven Trade Alerts - baoquankhu1.vn
Portfolio Recap: Is BCGWW a good ESG investment2025 Market Overview & Community Verified Swing Trade Signals - baoquankhu1.vn
Quarterly Risk: Does Evolus Inc have high return on assetsJuly 2025 WrapUp & High Accuracy Swing Trade Signals - baoquankhu1.vn
Tech Rally: Is TRTNPRC stock a value trapWeekly Risk Report & Stock Portfolio Risk Management - baoquankhu1.vn
Market Pulse: Will Gyre Therapeutics Inc outperform tech stocksJuly 2025 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
Ideas Watch: What are analysts price targets for Gyre Therapeutics IncIPO Watch & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Gains Report: How Gyre Therapeutics Inc stock valuations compare to rivalsJuly 2025 Sentiment & Weekly Stock Breakout Alerts - Bộ Nội Vụ
High Growth Tech Stocks To Watch In The US Market January 2026 - simplywall.st
How Gyre Therapeutics Inc. stock compares to growth peersTrade Risk Assessment & Safe Entry Point Alerts - Улправда
Aug Big Picture: Will Gyre Therapeutics Inc stock benefit from commodity pricesJuly 2025 Closing Moves & Reliable Intraday Trade Alerts - Bộ Nội Vụ
Will Dynagas LNG Partners LP stock deliver consistent dividends2025 Breakouts & Breakdowns & Verified Short-Term Plans - Улправда
What margin trends mean for Mach Natural Resources LP stockSwing Trade & Capital Efficiency Focused Ideas - Улправда
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.7%Time to Sell? - MarketBeat
Gyre Therapeutics, Inc. Announces Completion of the Pre-NDA Meeting on the Regulatory Strategy for F351 - marketscreener.com
GNI Group’s F351 Secures Path Toward Conditional Approval and Priority Review in China - TipRanks
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpShould You Buy? - MarketBeat
Gyre Therapeutics stock soars after positive pre-NDA meeting in China - Investing.com Nigeria
Gyre Therapeutics stock soars after positive pre-NDA meeting in China By Investing.com - Investing.com South Africa
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday - Benzinga
Gyre Pharmaceuticals advances liver fibrosis drug toward China approval By Investing.com - Investing.com Canada
Gyre Therapeutics Announces Pre-NDA Meeting Success for Hydronidone - TradingView — Track All Markets
0.11%
6.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):